rs104894520
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM1PM2PP3_ModeratePP5_Very_Strong
The NM_001136472.2(LITAF):c.344C>A(p.Thr115Asn) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Consequence
LITAF
NM_001136472.2 missense
NM_001136472.2 missense
Scores
7
11
1
Clinical Significance
Conservation
PhyloP100: 7.18
Genes affected
LITAF (HGNC:16841): (lipopolysaccharide induced TNF factor) Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PM1
In a domain LITAF (size 84) in uniprot entity LITAF_HUMAN there are 9 pathogenic changes around while only 0 benign (100%) in NM_001136472.2
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.885
PP5
Variant 16-11553566-G-T is Pathogenic according to our data. Variant chr16-11553566-G-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 6058.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553566-G-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LITAF | NM_001136472.2 | c.344C>A | p.Thr115Asn | missense_variant | 3/4 | ENST00000622633.5 | NP_001129944.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LITAF | ENST00000622633.5 | c.344C>A | p.Thr115Asn | missense_variant | 3/4 | 1 | NM_001136472.2 | ENSP00000483114.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Charcot-Marie-Tooth disease type 1C Pathogenic:2Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jan 14, 2003 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Mar 17, 2021 | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant has been reported to affect LITAF protein function (PMID: 23576546, 25058650, 25963657). This variant has been observed in individual(s) with clinical features of Charcot-Marie-Tooth disease (PMID: 12525712, Invitae). ClinVar contains an entry for this variant (Variation ID: 6058). This variant is not present in population databases (ExAC no frequency). This sequence change replaces threonine with asparagine at codon 115 of the LITAF protein (p.Thr115Asn). The threonine residue is highly conserved and there is a small physicochemical difference between threonine and asparagine. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Nov 07, 2018 | Not found in the total gnomAD dataset, and the data is high quality (0/282336 chr). Predicted to have a damaging effect on the protein. Damaging to protein function(s) relevant to disease mechanism. Very strong co-segregation with disease in affected and unaffected individuals, but from a single family. - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 01, 2024 | Not observed at significant frequency in large population cohorts (gnomAD); Published functional studies suggest a damaging effect on exosome production (PMID: 23576546); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25963657, 25058650, 12525712, 23576546) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D;D;.;D;.;D;.;D;D;D;.;.;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;.;.;D;.;D;.;.;D;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M;M;M;M;M;M;.;M;M;.;.;M;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;.;D;D;D;.;.;.;.;.;.;.;.;.
REVEL
Pathogenic
Sift
Uncertain
.;.;D;D;D;.;.;.;.;.;.;.;.;.
Sift4G
Uncertain
D;D;D;D;D;D;D;D;D;.;.;D;.;D
Polyphen
D;D;.;D;.;D;.;D;D;.;.;.;.;.
Vest4
MutPred
Gain of catalytic residue at T115 (P = 0.0478);Gain of catalytic residue at T115 (P = 0.0478);Gain of catalytic residue at T115 (P = 0.0478);Gain of catalytic residue at T115 (P = 0.0478);Gain of catalytic residue at T115 (P = 0.0478);Gain of catalytic residue at T115 (P = 0.0478);.;Gain of catalytic residue at T115 (P = 0.0478);Gain of catalytic residue at T115 (P = 0.0478);Gain of catalytic residue at T115 (P = 0.0478);Gain of catalytic residue at T115 (P = 0.0478);Gain of catalytic residue at T115 (P = 0.0478);Gain of catalytic residue at T115 (P = 0.0478);Gain of catalytic residue at T115 (P = 0.0478);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at